Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas Y Shapiro

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Evolution; International Journal of Organic Evolution|May 31, 2017
EVALUATING KINSHIP OF NEWLY SETTLED JUVENILES WITHIN SOCIAL GROUPS OF THE CORAL REEF FISH ANTHIAS SQUAMIPINNISJohn C Avise, Douglas Y Shapiro
Pain Physician|February 2, 2010
Dose conversion between tapentadol immediate and extended release for low back painMila S Etropolski, Akiko Okamoto, Douglas Y Shapiro, et al.
Current Medical Research and Opinion|December 18, 2010
Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: results of a randomized-withdrawal, placebo-controlled trialSherwyn Schwartz, Mila Etropolski, Douglas Y Shapiro, et al.
Diabetes Care|May 23, 2014
A randomized withdrawal, placebo-controlled study evaluating the efficacy and tolerability of tapentadol extended release in patients with chronic painful diabetic peripheral neuropathyAaron I Vinik, Douglas Y Shapiro, Christine Rauschkolb, et al.
Addiction (Abingdon, England)|January 16, 2013
A comparison among tapentadol tamper-resistant formulations (TRF) and OxyContin® (non-TRF) in prescription opioid abusersSuzanne K Vosburg, Jermaine D Jones, Jeanne M Manubay, et al.
Expert Opinion on Pharmacotherapy|June 29, 2010
Efficacy and safety of tapentadol extended release for the management of chronic low back pain: results of a prospective, randomized, double-blind, placebo- and active-controlled Phase III studyRobert Buynak, Douglas Y Shapiro, Akiko Okamoto, et al.
Clinical Drug Investigation|December 16, 2014
A pooled analysis evaluating the efficacy and tolerability of tapentadol extended release for chronic, painful diabetic peripheral neuropathySherwyn Schwartz, Mila S Etropolski, Douglas Y Shapiro, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Evolution; International Journal of Organic Evolution|May 31, 2017
EVALUATING KINSHIP OF NEWLY SETTLED JUVENILES WITHIN SOCIAL GROUPS OF THE CORAL REEF FISH ANTHIAS SQUAMIPINNISJohn C Avise, Douglas Y Shapiro
Pain Physician|February 2, 2010
Dose conversion between tapentadol immediate and extended release for low back painMila S Etropolski, Akiko Okamoto, Douglas Y Shapiro, et al.
Current Medical Research and Opinion|December 18, 2010
Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: results of a randomized-withdrawal, placebo-controlled trialSherwyn Schwartz, Mila Etropolski, Douglas Y Shapiro, et al.
Diabetes Care|May 23, 2014
A randomized withdrawal, placebo-controlled study evaluating the efficacy and tolerability of tapentadol extended release in patients with chronic painful diabetic peripheral neuropathyAaron I Vinik, Douglas Y Shapiro, Christine Rauschkolb, et al.
Addiction (Abingdon, England)|January 16, 2013
A comparison among tapentadol tamper-resistant formulations (TRF) and OxyContin® (non-TRF) in prescription opioid abusersSuzanne K Vosburg, Jermaine D Jones, Jeanne M Manubay, et al.
Expert Opinion on Pharmacotherapy|June 29, 2010
Efficacy and safety of tapentadol extended release for the management of chronic low back pain: results of a prospective, randomized, double-blind, placebo- and active-controlled Phase III studyRobert Buynak, Douglas Y Shapiro, Akiko Okamoto, et al.
Clinical Drug Investigation|December 16, 2014
A pooled analysis evaluating the efficacy and tolerability of tapentadol extended release for chronic, painful diabetic peripheral neuropathySherwyn Schwartz, Mila S Etropolski, Douglas Y Shapiro, et al.
Pageof 1